China Rhetoric Could Be Key To US FDA IT System Upgrade
Executive Summary
FDA Commissioner Robert Califf says mentioning China helps increase congressional support.
You may also be interested in...
Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals
No negative actions have been taken in the US FDA’s oncology review divisions, but vague diversity guidance continues to raise concerns.
Some US FDA Decisions May Have Been Different If Technology Had Been Upgraded, Woodcock Says
Principal Deputy Commissioner Woodcock is overseeing an enterprise-wide technology campaign intended to improve access to agency information and data.
Vid Desai On How US FDA’s Modernization Will Improve Inspections And Drug Reviews
FDA’s chief information officer talks to the Pink Sheet about why the agency relied on COVID data from foreign countries, and describes pilot projects to target inspections and manage warehouse data.